Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Arcinova Invests in State of the Art LC-MS Equipment

Designed for the most demanding bioanalytical quantitative UPLC-MS/MS applications, the latest Waters Xevo TQ XS has provided ARCINOVA with the ultimate in tandem quadrupole performance to ensure class leading sensitivity and robustness. In combination with our MSIA (mass spectrometric immuno-assay) extraction system the Xevo provides us with a powerful and sensitive hybrid LC-MS  solution for peptide and biomolecule analysis. For any application, either small or large molecules, our new Xevo mass spectrometer and I-Class Acquity UPLC system ensures that ARCINOVA can provide our clients with the highest quality scientific information when they need it most.

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.